4//SEC Filing
Moll Thomas 4
Accession 0001387131-18-000778
CIK 0000887247other
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 5:53 PM ET
Size
7.7 KB
Accession
0001387131-18-000778
Insider Transaction Report
Form 4
Moll Thomas
Vice President of Research
Transactions
- Award
Restricted Stock Units
2018-02-21+41,733→ 41,733 total→ Common Stock (41,733 underlying) - Award
Employee Stock Option (right to buy)
2018-02-21+83,467→ 83,467 totalExercise: $2.83Exp: 2028-02-21→ Common Stock (83,467 underlying)
Footnotes (2)
- [F1]The option vests and becomes exercisable as to 1/36 of the option shares on each monthly anniversary of the grant date.
- [F2]Each restricted stock unit (RSU) represents a contingent right to receive one share of the issuer's common stock. 1/3 of the RSUs vest on each anniversary of the grant date over a three year period provided that the Reporting Person has continued to provide services to the Company during such period.
Documents
Issuer
Adamis Pharmaceuticals Corp
CIK 0000887247
Entity typeother
Related Parties
1- filerCIK 0001530181
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 5:53 PM ET
- Size
- 7.7 KB